Overview of the Study
This research focuses on the use of Stim Assist, an AI-driven clinical decision support software, in optimizing ovarian stimulation for IVF patients. The study involved a total of 291 patients treated with Stim Assist between December 2022 and April 2023, compared to a control group of historical patients. The software features two main tools: the Starting Dose Tool, which helps determine the optimal starting dose of FSH, and the Trigger Tool, which predicts the number of mature eggs based on current follicle sizes and hormone levels.
Key Details
- The Starting Dose Tool uses a K-nearest neighbors algorithm to analyze data from over 20,000 previous IVF cycles, predicting the best FSH dose for individual patients.
- The Trigger Tool assesses follicle sizes and estradiol levels to forecast the number of mature eggs that can be retrieved if triggering today, tomorrow, or in two days.
- Clinicians could adjust doses and trigger timing based on the predictions from Stim Assist, allowing for personalized treatment plans.
- Data was collected from medical charts and electronic health records, ensuring a robust analysis of outcomes between the treatment and control groups.
Importance of the Research
This study highlights the potential of AI in enhancing IVF treatment by providing tailored recommendations based on historical data. By integrating technology into clinical practice, healthcare providers can make more informed decisions, ultimately improving patient outcomes. The findings suggest that AI tools like Stim Assist could revolutionize how IVF is approached, leading to better egg retrieval rates and more effective treatment strategies. As reproductive technology continues to evolve, understanding and implementing these innovations is crucial for advancing patient care.
